For episode 28 we connect with Trevor Martin, Co-Founder & CEO of Mammoth Bioscience.  Learn how Mammoth is utilizing CRISPR technology to develop innovative genetic treatments, and what challenges a platform biotech company like themselves faces as they grow and work towards their goals.

First In Human is a biotech-focused podcast that interviews industry leaders and investors to learn about their journey to in-human clinical trials. Presented by Vial, a tech-enabled CRO, hosted by Simon Burns, CEO & Co-Founder & guest host Co-Founder, Andrew Brackin. Episodes launch weekly on Tuesdays. To view the full transcript of this episode, click here.